Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice

Not Applicable

Completed

• Conditions: Medication Therapy Management; Pharmacogenomics
• Interventions: Other: Medication therapy management

• Registration Number: NCT02748148
• Lead Sponsor: Tabula Rasa HealthCare

Brief Summary

The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.

Detailed Description

The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.

Study Timeline

• Study Start: 2016-04
• Study First Submitted: 2016-04-01
• Study First Submitted QC: 2016-04-19
• Study First Posted: 2016-04-22
• Primary Completion: 2016-09
• Study Completion: 2016-09
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-14
• Last Update Posted: 2016-10-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Receiving primary health care from Elmwood Family Physicians; and
• Medicare beneficiary; and
• Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem

Exclusion Criteria

• Not willing to participate in the study and sign informed consent; or
• Non-English speaking or designated surrogate as translator not available

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Medication therapy management	Medication therapy management	Medication therapy management service that is enhanced by the incorporation of pharmacogenomics and medication risk mitigation factor technology

Primary Outcome Measures

Name	Time	Method
Qualitative description of process-related challenges and successes as assessed by observation and survey	3 months	Implementation

Secondary Outcome Measures

Name	Time	Method
Quantitative description of bidirectional communication as assessed by turn-around times from pharmacist's recommendations delivered to prescriber's responses received	3 months	Communication
Qualitative description of incorporation of pharmacogenomic testing into workflow and receptiveness as assessed by observation and survey	3 months	Pharmacogenomic testing
Qualitative description of prescriber satisfaction with enhanced medication therapy management services as assessed by survey	3 months	Prescriber survey
Qualitative and quantitative description of potential impact of enhanced medication therapy management services on drug regimens as assessed by before-and-after observations	3 months	Impact

Trial Locations

Locations (1)

Elmwood Family Physicians; 🇺🇸 Marlton, New Jersey, United States